Clinical trial

Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

NCT02607410

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-01-01

PhasePHASE4

Study timeline

Study start (unknown)2010-01-01Date precision: month

Registry last updated2015-11-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

sitagliptinDRUG · verified · RxNorm: sitagliptin

NPH insulinDRUG

Sponsors & collaborators

University of Sao Paulo General Hospitallead sponsor

Fundação de Amparo à Pesquisa do Estado de São Paulocollaborator

Mapped research locations

São PauloSão Paulo, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02607410 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.